Chemoinformaics analysis of (3S,9R,10R)-heptadeca-4,6-diyne-3,9,10-triol
Molecular Weight | 280.408 | nRot | 9 |
Heavy Atom Molecular Weight | 252.184 | nRig | 15 |
Exact Molecular Weight | 280.204 | nRing | 0 |
Solubility: LogS | -5.657 | nHRing | 0 |
Solubility: LogP | 4.867 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 49.4662 |
nHD | 3 | BPOL | 28.0898 |
QED | 0.553 |
Synth | 6.165 |
Natural Product Likeliness | 2.926 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.763 |
MDCK | 0.0000171 |
BBB | 0.578 |
PPB | 0.954976 |
VDSS | 1.496 |
FU | 0.0467355 |
CYP1A2-inh | 0.178 |
CYP1A2-sub | 0.679 |
CYP2c19-inh | 0.202 |
CYP2c19-sub | 0.948 |
CYP2c9-inh | 0.204 |
CYP2c9-sub | 0.612 |
CYP2d6-inh | 0.159 |
CYP2d6-sub | 0.74 |
CYP3a4-inh | 0.705 |
CYP3a4-sub | 0.264 |
CL | 17.934 |
T12 | 0.084 |
hERG | 0.04 |
Ames | 0.048 |
ROA | 0.093 |
SkinSen | 0.407 |
Carcinogencity | 0.086 |
EI | 0.168 |
Respiratory | 0.931 |
NR-Aromatase | 0.118 |
Antiviral | Yes |
Prediction | 0.782576 |